SEARCH RESULTS FOR: 什么烟让人闻了听话(打开网站:maiyao88.com)喷雾5秒昏睡货到付款哪里找93539(9102 results)

Export results
Filters
Sort By
10
Results Per Page
10
Results/Pg
Company Name Brand Name GMDN Term Name GMDN Term Status FDA Product Code Name FDA Product Code Device Packaged As Sterile Sterilization Prior To Use Issuing Agency Device Size Device Size Type Device Class Implantable

Show Filters

CP Stent™ - 04046964899140

MCP022 Mounted CP Stent 3.9 24 4 9F
B BRAUN INTERVENTIONAL SYSTEMS, INC
614333
In Commercial Distribution

  • 04046964899140 ()

  • Diameter (mm) : 24.000 MM
  • Length : 39.000 MM
614333

  • Bare-metal aortic stent

CP Stent™ - 04046964899133

MCP021 Mounted CP Stent 3.9 22 4 9F
B BRAUN INTERVENTIONAL SYSTEMS, INC
614332
In Commercial Distribution

  • 04046964899133 ()

  • Length : 39.000 MM
  • Diameter (mm) : 22.000 MM
614332

  • Bare-metal aortic stent

CP Stent™ - 04046964899126

MCP020 Mounted CP Stent 3.9 20 4 9F
B BRAUN INTERVENTIONAL SYSTEMS, INC
614331
In Commercial Distribution

  • 04046964899126 ()

  • Length : 39.000 MM
  • Diameter (mm) : 20.000 MM
614331

  • Bare-metal aortic stent

TUBING SYSTEM FOR PLASMAPHERESIS - 18855036020688

Indications for FH: The Tubing System for Plasmapheresis NK-M3R(U) is one of three disposable device components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in performing low density lipoprotein cholesterol (LDL-C) apheresis to acutely remove LDL-C from the plasma. Indications for FSGS: The Tubing System for Plasmapheresis NK-M3R(U) is one of three disposable device components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in the treatment of adult and pediatric patients with nephrotic syndrome associated with primary focal segmental glomerulosclerosis (FSGS).
KANEKA PHARMA AMERICA LLC
NK-M3R(UL)
In Commercial Distribution

  • 18855036020688 ()
  • 28855036020685 ()


  • Apheresis system tubing set

TUBING SYSTEM FOR PLASMAPHERESIS - 18855036012850

Indications for FH: The Tubing System for Plasmapheresis NK-M3R(U) is one of three disposable device components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in performing low density lipoprotein cholesterol (LDL-C) apheresis to acutely remove LDL-C from the plasma. Indications for FSGS: The Tubing System for Plasmapheresis NK-M3R(U) is one of three disposable device components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in the treatment of adult and pediatric patients with nephrotic syndrome associated with primary focal segmental glomerulosclerosis (FSGS).
KANEKA PHARMA AMERICA LLC
NK-M3R(U)
In Commercial Distribution

  • 18855036012850 ()
  • 28855036012857 ()


  • Apheresis system tubing set

Hancock™ - 00763000517847

CONDUIT HC150-25 HK1 MO 26L
MEDTRONIC, INC.
HC150-25
In Commercial Distribution

  • 00763000517847 ()

  • 25 MM


  • Pulmonary open-surgery heart valve bioprosthesis

Hancock™ - 00763000517830

CONDUIT HC15022 HK1 MO 26L
MEDTRONIC, INC.
HC150-22
In Commercial Distribution

  • 00763000517830 ()

  • 22 MM


  • Pulmonary open-surgery heart valve bioprosthesis

Hancock™ - 00763000517823

CONDUIT HC150-20 HK1 MO 26L
MEDTRONIC, INC.
HC150-20
In Commercial Distribution

  • 00763000517823 ()

  • 20 MM


  • Pulmonary open-surgery heart valve bioprosthesis

Hancock™ - 00763000517816

CONDUIT HC150-18 HK1 MO 26L
MEDTRONIC, INC.
HC150-18
In Commercial Distribution

  • 00763000517816 ()

  • 18 MM


  • Pulmonary open-surgery heart valve bioprosthesis

Hancock™ - 00763000517809

CONDUIT HC150-16 HK1 MO 26L
MEDTRONIC, INC.
HC150-16
In Commercial Distribution

  • 00763000517809 ()

  • 16 MM


  • Pulmonary open-surgery heart valve bioprosthesis
< 1 ... 588 589 590 591 592 ... 911 >